Shiseido's Strategic Realignment: Job Cuts in the U.S. and Drunk Elephant's Future
Shiseido is undertaking a significant strategic overhaul, marked by workforce reductions in its U.S. division, a direct consequence of persistent financial challenges associated with its Drunk Elephant skincare line. This move, part of a broader global cost-cutting initiative, comes as the company navigates a complex market landscape, seeking to restore profitability in key regions while repositioning underperforming assets. The half-year financial results reveal a mixed performance, with positive gains in some markets overshadowed by a notable operating loss in the United States, underscoring the urgent need for these decisive actions.
The Japanese cosmetics giant has announced plans to eliminate 300 positions in its American operations. This decision is closely linked to the continued underperformance of its premium skincare brand, Drunk Elephant, which has been a significant contributor to a ¥5.8 billion operating loss in the U.S. market. The challenges faced by Drunk Elephant are not new; the brand encountered considerable supply chain disruptions in 2024. These issues led to a decline in customer engagement and subsequently impacted its financial results across both the U.S. and European territories.
Despite these setbacks in the Western markets, Shiseido's overall financial health for the first half of 2025 showed some resilience. Strategic restructuring efforts, particularly within its Japanese and Chinese markets, played a crucial role in boosting the company's net profit to a respectable ¥9.5 billion. However, this positive development was tempered by a 10% decrease in U.S. sales, highlighting the uneven nature of its global performance and the specific hurdles it faces in North America.
Looking ahead, Shiseido has articulated clear intentions to revitalize the Drunk Elephant brand, with a comprehensive repositioning strategy slated to commence in 2026. This repositioning is a critical component of Shiseido's wider objective to achieve substantial cost savings. The company projects an impressive ¥15 billion in cost efficiencies from its U.S. operations by 2026. This aggressive cost-reduction target underscores the company's commitment to streamlining operations and improving financial stability.
The current strategic adjustments by Shiseido are a direct response to prior acquisition missteps and a generally subdued skincare market in the United States. The organization is rigorously focusing on global cost containment, indicating a shift towards a more disciplined financial approach. A new mid-term strategic blueprint is anticipated to be unveiled by the end of the year, which is expected to provide further details on how Shiseido intends to navigate future market complexities and ensure sustainable growth across its diverse brand portfolio.
Shiseido's recent measures, including job cuts and strategic brand re-evaluations, signify a pivotal moment for the company as it confronts persistent profitability issues in the U.S. market, largely stemming from its Drunk Elephant brand. These actions, coupled with ongoing restructuring and a focus on cost reduction, underscore a determined effort to fortify its financial foundation and adapt to evolving market dynamics, with a revised mid-term plan on the horizon to guide its future trajectory.